{"id":8938,"date":"2020-12-01T14:34:28","date_gmt":"2020-12-01T17:34:28","guid":{"rendered":"https:\/\/academiadepacientes.com.br\/?p=8938"},"modified":"2020-12-01T14:34:28","modified_gmt":"2020-12-01T17:34:28","slug":"conitec-nao-recomenda-incorporacao-de-canabidiol-para-esclerose-multipla","status":"publish","type":"post","link":"https:\/\/academiadepacientes.com.br\/?p=8938","title":{"rendered":"Conitec N\u00c3O recomenda incorpora\u00e7\u00e3o de canabidiol para esclerose m\u00faltipla"},"content":{"rendered":"

\"\"<\/p>\n

RADAR ATS \u00e9 o seu observat\u00f3rio independente sobre a atua\u00e7\u00e3o da Conitec no campo das doen\u00e7as raras<\/strong> <\/div><\/div>\n

F<\/span>oi publicada no Diario Oficial da Uni\u00e3o (DOU) de ontem (31\/11) \u00a0a decis\u00e3o de N\u00c3O incorporar o tetraidrocanabinol 27mg\/ml + canabidiol 25mg\/ml para o tratamento sintom\u00e1tico da espasticidade moderada a grave relacionada \u00e0 esclerose m\u00faltipla<\/b>., no \u00e2mbito do Sistema \u00danico de Sa\u00fade \u2013 SUS.<\/p>\n

At\u00e9 o momento desta publica\u00e7\u00e3o no blog, os relat\u00f3rios com as considera\u00e7\u00f5es preliminares das consultas p\u00fablicas ainda n\u00e3o foram disponibilizados no site da CONITEC<\/p>\n

[pdf-embedder url=”https:\/\/academiadepacientes.com.br\/wp-content\/uploads\/2020\/12\/DOU-30-11-2020-Decisoes-CONITEC-2.pdf” title=”DOU – 30-11-2020 – Decis\u00f5es CONITEC 2″]\n","protected":false},"excerpt":{"rendered":"

oi publicada no Diario Oficial da Uni\u00e3o (DOU) de ontem (31\/11) \u00a0a decis\u00e3o de N\u00c3O incorporar o tetraidrocanabinol 27mg\/ml + … <\/p>\n

Saiba mais<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[109],"tags":[75,74],"class_list":["post-8938","post","type-post","status-publish","format-standard","hentry","category-radar-ats","tag-ats","tag-conitec","infinite-scroll-item"],"aioseo_notices":[],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"mailpoet_newsletter_max":false},"uagb_author_info":{"display_name":"Cl\u00e1udio Cordovil","author_link":"https:\/\/academiadepacientes.com.br\/?author=2"},"uagb_comment_info":0,"uagb_excerpt":"oi publicada no Diario Oficial da Uni\u00e3o (DOU) de ontem (31\/11) \u00a0a decis\u00e3o de N\u00c3O incorporar o tetraidrocanabinol 27mg\/ml + ... Saiba mais","_links":{"self":[{"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=\/wp\/v2\/posts\/8938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8938"}],"version-history":[{"count":0,"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=\/wp\/v2\/posts\/8938\/revisions"}],"wp:attachment":[{"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/academiadepacientes.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}